JPWO2022060488A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022060488A5 JPWO2022060488A5 JP2023517698A JP2023517698A JPWO2022060488A5 JP WO2022060488 A5 JPWO2022060488 A5 JP WO2022060488A5 JP 2023517698 A JP2023517698 A JP 2023517698A JP 2023517698 A JP2023517698 A JP 2023517698A JP WO2022060488 A5 JPWO2022060488 A5 JP WO2022060488A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- composition
- seq
- peptide
- adjuvant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063080619P | 2020-09-18 | 2020-09-18 | |
| US63/080,619 | 2020-09-18 | ||
| PCT/US2021/045058 WO2022060488A1 (en) | 2020-09-18 | 2021-08-06 | Multiepitope vaccine for the treatment of alzheimer's disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023541670A JP2023541670A (ja) | 2023-10-03 |
| JPWO2022060488A5 true JPWO2022060488A5 (enExample) | 2025-08-19 |
Family
ID=80777125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023517698A Pending JP2023541670A (ja) | 2020-09-18 | 2021-08-06 | アルツハイマー病の処置のためのマルチエピトープワクチン |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230355729A1 (enExample) |
| EP (1) | EP4213941A4 (enExample) |
| JP (1) | JP2023541670A (enExample) |
| KR (1) | KR20230087499A (enExample) |
| CN (1) | CN116438191A (enExample) |
| AR (1) | AR123187A1 (enExample) |
| AU (1) | AU2021345483A1 (enExample) |
| CA (1) | CA3192387A1 (enExample) |
| IL (1) | IL301262A (enExample) |
| MX (1) | MX2023003008A (enExample) |
| TW (1) | TW202227464A (enExample) |
| WO (1) | WO2022060488A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12227567B2 (en) | 2017-07-25 | 2025-02-18 | Truebinding, Inc. | Treating cancer by blocking the interaction of TIM-3 and its ligand |
| CN116063520A (zh) | 2019-01-30 | 2023-05-05 | 真和制药有限公司 | 抗gal3抗体及其用途 |
| CN116157151A (zh) | 2020-05-26 | 2023-05-23 | 真和制药有限公司 | 通过阻断半乳凝素-3治疗炎性疾病的方法 |
| AU2023223603A1 (en) | 2022-02-28 | 2024-08-22 | Tridem Bioscience Gmbh & Co Kg | A CONJUGATE CONSISTING OF OR COMPRISING AT LEAST A ß-GLUCAN OR A MANNAN. |
| EP4486388A1 (en) | 2022-02-28 | 2025-01-08 | Tridem Bioscience GmbH & Co KG | A conjugate consisting of or comprising at least a ss-glucan or a mannan |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2885924C (en) * | 2012-08-21 | 2022-12-13 | Institute For Molecular Medicine, Inc. | Compositions and methods related to diseases associated with deposits of amyloid, tau, and alpha-synuclein |
| UA118441C2 (uk) * | 2012-10-08 | 2019-01-25 | Протена Біосаєнсиз Лімітед | Антитіло, що розпізнає альфа-синуклеїн |
| CA2944402A1 (en) * | 2014-04-08 | 2015-10-15 | Prothena Biosciences Limited | Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein |
| US10745456B2 (en) * | 2015-04-01 | 2020-08-18 | The Scripps Research Institute | Methods and compositions related to GPCR agonist polypeptides |
| JP2023507949A (ja) * | 2019-12-30 | 2023-02-28 | スマート リキッド クリスタル テクノロジーズ カンパニー リミテッド | 感熱発色型液晶マイクロカプセル及びその製造方法、並びに感熱発色型容器 |
| AU2021276401A1 (en) * | 2020-05-19 | 2022-12-15 | Othair Prothena Limited | Multi-epitope vaccine for the treatment of Alzheimer's disease |
| KR20230080397A (ko) * | 2020-08-07 | 2023-06-07 | 오타이르 프로테나 리미티드 | 알츠하이머 질환을 치료하기 위한 멀티에피토프 백신 |
-
2021
- 2021-08-06 MX MX2023003008A patent/MX2023003008A/es unknown
- 2021-08-06 JP JP2023517698A patent/JP2023541670A/ja active Pending
- 2021-08-06 CA CA3192387A patent/CA3192387A1/en active Pending
- 2021-08-06 IL IL301262A patent/IL301262A/en unknown
- 2021-08-06 KR KR1020237012950A patent/KR20230087499A/ko active Pending
- 2021-08-06 EP EP21869944.5A patent/EP4213941A4/en active Pending
- 2021-08-06 WO PCT/US2021/045058 patent/WO2022060488A1/en not_active Ceased
- 2021-08-06 US US18/245,532 patent/US20230355729A1/en active Pending
- 2021-08-06 CN CN202180064030.7A patent/CN116438191A/zh active Pending
- 2021-08-06 AU AU2021345483A patent/AU2021345483A1/en active Pending
- 2021-08-09 TW TW110129344A patent/TW202227464A/zh unknown
- 2021-08-09 AR ARP210102218A patent/AR123187A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI355390B (en) | Immunogenic peptide carrier conjugates and methods | |
| Valmori et al. | Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination. | |
| US10596238B2 (en) | Methods and compositions related to immunogenic fibrils | |
| JP2002528515A (ja) | 多成分髄膜炎菌ワクチン | |
| JPH0674210B2 (ja) | 抗原の免疫原性の増強 | |
| US9849174B2 (en) | Methods and compositions related to immunogenic fibrils | |
| JP4063879B2 (ja) | 所望の決定基に対する免疫応答の誘導 | |
| CA2596730A1 (en) | Adjuvanting material comprising pam2cys or pam3cys covalently linked to a metal chelating group | |
| US20030175285A1 (en) | Molecule of pharmaceutical interest comprising at its n-terminal a glutamic acid or a glutamine in the form of a physiologically acceptable strong acid | |
| JPWO2021236809A5 (enExample) | ||
| US20050049197A1 (en) | Induction of immune response against desired determinants | |
| JPH05505188A (ja) | 合成ポリペプチド | |
| JP3057748B2 (ja) | 細胞毒性ｔリンパ球の特異的誘導用合成ワクチン | |
| JPWO2022060488A5 (enExample) | ||
| JPWO2022032166A5 (enExample) | ||
| EP0289110A2 (en) | Conjugate malaria vaccine | |
| JPWO2022060424A5 (enExample) | ||
| EP0912195B1 (en) | Vaccine comprising antigens bound to carriers through labile bonds | |
| KR100887591B1 (ko) | 특정의 교차 반응성을 증가시키는 항원성 구조들의 제조방법 | |
| CA2363118A1 (en) | Immunogens comprising a peptide and a carrier derived from h.influenzae protein d | |
| JPWO2022060487A5 (enExample) | ||
| JPWO2022031342A5 (enExample) | ||
| CA2696068A1 (en) | Compositions and methods for the treatment and prophylaxis of hypertension | |
| Rojo | Dendritic compounds as immune response modulators. New approaches for vaccine development | |
| US20050255561A1 (en) | Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers |